A comprehensive evaluation of available evidence of mavacamten in obstructive HCM: a meta-analysis of randomised controlled trials.
Event:
ESC Congress 2024
Topic:
Hypertrophic Cardiomyopathy
Session:
Cardiac myosin inhibitors for treatment of hypertrophic obstructive cardiomyopathy
